The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
Condit, Richard C.
Robertson, James S.
Fast, Patricia E.
Smith, Emily R.
Chen, Robert T
For the Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)
MetadataShow full item record
Summary in foreign language
Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines.
Palabras claveBrighton Collaboration; CEPI; Vaccine; Benefit-risk; Safety; Protein; Recombinant; Peptide; Template
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.